Fundraising FoxBayMed Venture Partners — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management.
AI & Machine LearningDigital HealthHealthtechMedical DevicesChicago, US
Amit Gupta(Co-founder, Advisor)inMozziyar Etemadi(Co-founder, Head of AI)Omer Inan(Co-founder, Chief Scientific Officer)inAndrew Carek(Co-founder, Chief Technical Officer)inEric Meizlish(Chief Executive Officer)inJohn D. Martin(Chief Medical Officer)in
Co-investorsBroadview VenturesCross-Border Impact VenturesLaerdal Million Lives FundOSF VenturesPortal InnovationsArboretum Ventures+1 more
Embolx is a commercial-stage medical device company developing microcatheters for arterial embolization procedures used to treat conditions such as cancerous tumors, benign prostatic hyperplasia, and uterine fibroids.
HardwareHealthtechMedical DevicesSunnyvale, US
Robert J.J. de Neve(Executive Officer, Director)Michael Allen(President & CEO)inNORMAN GITIS(Director)Paul Rogan(Director)FRANK GRILLO(Director)inTIANHONG XU(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.